Functional characterization of nine novel naturally occurring human melanocortin-3 receptor mutations

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1822, Issue 11, 2012, Pages 1752-1761

  Yang, Fan ^a   Tao, Ya Xiong ^a  

^a AUBURN UNIVERSITY   (United States)

Author keywords

Binding; Cell surface expression; Melanocortin 3 receptor; Naturally occurring mutations; Obesity; Signaling

Indexed keywords

MELANOCORTIN 3 RECEPTOR;

ARTICLE; CONTROLLED STUDY; GENE MUTATION; HUMAN; HUMAN CELL; LIGAND BINDING; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

AMINO ACID SUBSTITUTION; GENE EXPRESSION; HEK293 CELLS; HUMANS; LIGANDS; MUTATION; OBESITY; PROTEIN BINDING; RECEPTOR, MELANOCORTIN, TYPE 3; SIGNAL TRANSDUCTION; STRUCTURE-ACTIVITY RELATIONSHIP; TRANSFECTION;

EID: 84865078174     PISSN: 09254439     EISSN: 1879260X     Source Type: Journal    
DOI: 10.1016/j.bbadis.2012.07.017     Document Type: Article

References (52)

1. Spiegelman B.M., Flier J.S. Obesity and the regulation of energy balance. Cell 2001, 104:531-543.
2. Clement K., Vaisse C., Lahlou N., Cabrol S., Pelloux V., Cassuto D., Gourmelen M., Dina C., Chambaz J., Lacorte J.M., Basdevant A., Bougneres P., Lebouc Y., Froguel P., Guy-Grand B. A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction. Nature 1998, 392:398-401.
3. Krude H., Biebermann H., Luck W., Horn R., Brabant G., Gruters A. Severe early-onset obesity, adrenal insufficiency and red hair pigmentation caused by POMC mutations in humans. Nat. Genet. 1998, 19:155-157.
4. Farooqi I.S., Keogh J.M., Yeo G.S., Lank E.J., Cheetham T., O'Rahilly S. Clinical spectrum of obesity and mutations in the melanocortin 4 receptor gene. N. Engl. J. Med. 2003, 348:1085-1095.
5. Hinney A., Vogel C.I., Hebebrand J. From monogenic to polygenic obesity: recent advances. Eur. Child Adolesc. Psychiatry 2010, 19:297-310.
6. Chen A.S., Marsh D.J., Trumbauer M.E., Frazier E.G., Guan X.M., Yu H., Rosenblum C.I., Vongs A., Feng Y., Cao L., Metzger J.M., Strack A.M., Camacho R.E., Mellin T.N., Nunes C.N., Min W., Fisher J., Gopal-Truter S., MacIntyre D.E., Chen H.Y., Van der Ploeg L.H. Inactivation of the mouse melanocortin-3 receptor results in increased fat mass and reduced lean body mass. Nat. Genet. 2000, 26:97-102.
7. Butler A.A., Kesterson R.A., Khong K., Cullen M.J., Pelleymounter M.A., Dekoning J., Baetscher M., Cone R.D. A unique metabolic syndrome causes obesity in the melanocortin-3 receptor-deficient mouse. Endocrinology 2000, 141:3518-3521.
8. Zhang Y., Kilroy G.E., Henagan T.M., Prpic-Uhing V., Richards W.G., Bannon A.W., Mynatt R.L., Gettys T.W. Targeted deletion of melanocortin receptor subtypes 3 and 4, but not CART, alters nutrient partitioning and compromises behavioral and metabolic responses to leptin. FASEB J. 2005, 19:1482-1491.
9. Gantz I., Konda Y., Tashiro T., Shimoto Y., Miwa H., Munzert G., Watson S.J., DelValle J., Yamada T. Molecular cloning of a novel melanocortin receptor. J. Biol. Chem. 1993, 268:8246-8250.
10. Roselli-Rehfuss L., Mountjoy K.G., Robbins L.S., Mortrud M.T., Low M.J., Tatro J.B., Entwistle M.L., Simerly R.B., Cone R.D. Identification of a receptor for γ melanotropin and other proopiomelanocortin peptides in the hypothalamus and limbic system. Proc. Natl. Acad. Sci. U. S. A. 1993, 90:8856-8860.
11. Gantz I., Fong T.M. The melanocortin system. Am. J. Physiol. 2003, 284:E468-E474.
12. Ellacott K.L., Cone R.D. The role of the central melanocortin system in the regulation of food intake and energy homeostasis: lessons from mouse models. Philos. Trans. R. Soc. Lond. B Biol. Sci. 2006, 361:1265-1274.
13. Tao Y.X., Huang H., Wang Z.Q., Yang F., Williams J.N., Nikiforovich G.V. Constitutive activity of neural melanocortin receptors. Methods Enzymol. 2010, 484:267-279.
14. Humphreys M.H. γ-MSH, sodium metabolism, and salt-sensitive hypertension. Am. J. Physiol. 2004, 286:R417-R430.
15. Getting S.J., Riffo-Vasquez Y., Pitchford S., Kaneva M., Grieco P., Page C.P., Perretti M., Spina D. A role for MC3R in modulating lung inflammation. Pulm. Pharmacol. Ther. 2008, 21:866-873.
16. Jegou S., Boutelet I., Vaudry H. Melanocortin-3 receptor mRNA expression in pro-opiomelanocortin neurones of the rat arcuate nucleus. J. Neuroendocrinol. 2000, 12:501-505.
17. Cone R.D. The central melanocortin system and energy homeostasis. Trends Endocrinol. Metab. 1999, 10:211-216.
18. Marks D.L., Hruby V., Brookhart G., Cone R.D. The regulation of food intake by selective stimulation of the type 3 melanocortin receptor (MC3R). Peptides 2006, 27:259-264.
19. Sutton G.M., Perez-Tilve D., Nogueiras R., Fang J., Kim J.K., Cone R.D., Gimble J.M., Tschop M.H., Butler A.A. The melanocortin-3 receptor is required for entrainment to meal intake. J. Neurosci. 2008, 28:12946-12955.
20. Sutton G.M., Begriche K., Kumar K.G., Gimble J.M., Perez-Tilve D., Nogueiras R., McMillan R.P., Hulver M.W., Tschop M.H., Butler A.A. Central nervous system melanocortin-3 receptors are required for synchronizing metabolism during entrainment to restricted feeding during the light cycle. FASEB J. 2010, 24:862-872.
21. Tao Y.X. The melanocortin-4 receptor: physiology, pharmacology, and pathophysiology. Endocr. Rev. 2010, 31:506-543.
22. Lee Y.S., Poh L.K., Loke K.Y. A novel melanocortin 3 receptor gene (MC3R) mutation associated with severe obesity. J. Clin. Endocrinol. Metab. 2002, 87:1423-1426.
23. Feng N., Young S.F., Aguilera G., Puricelli E., Adler-Wailes D.C., Sebring N.G., Yanovski J.A. Co-occurrence of two partially inactivating polymorphisms of MC3R is associated with pediatric-onset obesity. Diabetes 2005, 54:2663-2667.
24. Lee Y.S., Poh L.K., Kek B.L., Loke K.Y. The role of melanocortin 3 receptor gene in childhood obesity. Diabetes 2007, 56:2622-2630.
25. Mencarelli M., Walker G.E., Maestrini S., Alberti L., Verti B., Brunani A., Petroni M.L., Tagliaferri M., Liuzzi A., Di Blasio A.M. Sporadic mutations in melanocortin receptor 3 in morbid obese individuals. Eur. J. Hum. Genet. 2008, 16:581-586.
26. Calton M.A., Ersoy B.A., Zhang S., Kane J.P., Malloy M.J., Pullinger C.R., Bromberg Y., Pennacchio L.A., Dent R., McPherson R., Ahituv N., Vaisse C. Association of functionally significant Melanocortin-4 but not Melanocortin-3 receptor mutations with severe adult obesity in a large North American case-control study. Hum. Mol. Genet. 2009, 18:1140-1147.
27. Mencarelli M., Dubern B., Alili R., Maestrini S., Benajiba L., Tagliaferri M., Galan P., Rinaldi M., Simon C., Tounian P., Hercberg S., Liuzzi A., Di Blasio A.M., Clement K. Rare melanocortin-3 receptor mutations with in vitro functional consequences are associated with human obesity. Hum. Mol. Genet. 2011, 20:392-399.
28. Zegers D., Beckers S., de Freitas F., Peeters A.V., Mertens I.L., Verhulst S.L., Rooman R.P., Timmermans J.P., Desager K.N., Massa G., Van Gaal L.F., Van Hul W. Identification of three novel genetic variants in the melanocortin-3 receptor of obese children. Obesity (Silver Spring) 2011, 19:152-159.
29. Tao Y.X. Mutations in the melanocortin-3 receptor (MC3R) gene: impact on human obesity or adiposity. Curr. Opin. Investig. Drugs 2010, 11:1092-1096.
30. K. Valli-Jaakola, Molecular genetic studies of melanocortin receptors in morbid obesity. PhD dissertation, Department of Medicine, University of Helsinki, Helsinki, Finland, 2007, 68 pp.
31. Chen C., Okayama H. High-efficiency transformation of mammalian cells by plasmid DNA. Mol. Cell. Biol. 1987, 7:2745-2752.
32. Fan Z.C., Sartin J.L., Tao Y.X. Molecular cloning and pharmacological characterization of porcine melanocortin-3 receptor. J. Endocrinol. 2008, 196:139-148.
33. Tao Y.X., Segaloff D.L. Functional characterization of melanocortin-4 receptor mutations associated with childhood obesity. Endocrinology 2003, 144:4544-4551.
34. Wang S.X., Fan Z.C., Tao Y.X. Functions of acidic transmembrane residues in human melanocortin-3 receptor binding and activation. Biochem. Pharmacol. 2008, 76:520-530.
35. Fan Z.C., Tao Y.X. Functional characterization and pharmacological rescue of melanocortin-4 receptor mutations identified from obese patients. J. Cell. Mol. Med. 2009, 13:3268-3282.
36. Wang Z.Q., Tao Y.X. Functional studies on twenty novel naturally occurring melanocortin-4 receptor mutations. Biochim. Biophys. Acta 2011, 1812:1190-1199.
37. Sawyer T.K., Sanfilippo P.J., Hruby V.J., Engel M.H., Heward C.B., Burnett J.B., Hadley M.E. 4-Norleucine, 7-D-phenylalanine-α-melanocyte-stimulating hormone: a highly potent α-melanotropin with ultralong biological activity. Proc. Natl. Acad. Sci. U. S. A. 1980, 77:5754-5758.
38. 8 on human MC3 receptor selectivity. J. Med. Chem. 2000, 43:4998-5002.
39. Tao Y.X. Functional characterization of novel melanocortin-3 receptor mutations identified from obese subjects. Biochim. Biophys. Acta 2007, 1772:1167-1174.
40. Tao Y.X. Inactivating mutations of G protein-coupled receptors and diseases: structure-function insights and therapeutic implications. Pharmacol. Ther. 2006, 111:949-973.
41. Tao Y.X. Molecular mechanisms of the neural melanocortin receptor dysfunction in severe early onset obesity. Mol. Cell. Endocrinol. 2005, 239:1-14.
42. Duan J., Wainwright M.S., Comeron J.M., Saitou N., Sanders A.R., Gelernter J., Gejman P.V. Synonymous mutations in the human dopamine receptor D2 (DRD2) affect mRNA stability and synthesis of the receptor. Hum. Mol. Genet. 2003, 12:205-216.
43. Ballesteros J.A., Weinstein H. Integrated methods for the construction of three-dimensional models and computational probing of structure-function relations in G protein-coupled receptors. Meth. Neurosci. 1995, 25:366-428.
44. Millar R.P., Newton C.L. The year in G protein-coupled receptor research. Mol. Endocrinol. 2010, 24:261-274.
45. Tao Y.X., Segaloff D.L. Functional characterization of melanocortin-3 receptor variants identify a loss-of-function mutation involving an amino acid critical for G protein-coupled receptor activation. J. Clin. Endocrinol. Metab. 2004, 89:3936-3942.
46. Rached M., Buronfosse A., Begeot M., Penhoat A. Inactivation and intracellular retention of the human I183N mutated melanocortin 3 receptor associated with obesity. Biochim. Biophys. Acta 2004, 1689:229-234.
47. Cone R.D. Haploinsufficiency of the melanocortin-4 receptor: part of a thrifty genotype?. J. Clin. Invest. 2000, 106:185-187.
48. Roth C.L., Ludwig M., Woelfle J., Fan Z.C., Brumm H., Biebermann H., Tao Y.X. A novel melanocortin-4 receptor gene mutation in a female patient with severe childhood obesity. Endocrine 2009, 36:52-59.
49. Mandrika I., Petrovska R., Wikberg J. Melanocortin receptors form constitutive homo- and heterodimers. Biochem. Biophys. Res. Commun. 2005, 326:349-354.
50. Tao Y.X., Johnson N.B., Segaloff D.L. Constitutive and agonist-dependent self-association of the cell surface human lutropin receptor. J. Biol. Chem. 2004, 279:5904-5914.
51. Biebermann H., Krude H., Elsner A., Chubanov V., Gudermann T., Gruters A. Autosomal-dominant mode of inheritance of a melanocortin-4 receptor mutation in a patient with severe early-onset obesity is due to a dominant-negative effect caused by receptor dimerization. Diabetes 2003, 52:2984-2988.
52. Muller M.J., Bosy-Westphal A., Krawczak M. Genetic studies of common types of obesity: a critique of the current use of phenotypes. Obes. Rev. 2010, 11:612-618.